<DOC>
	<DOCNO>NCT02465866</DOCNO>
	<brief_summary>This study compare relative bioavailability hydrocodone , acetaminophen , promethazine CL-108 ( hydrocodone 7.5mg/ acetaminophen 325 mg/ promethazine 12.5 mg ) manufacture Charleston Laboratories , Inc. hydrocodone Vicoprofen ( hydrocodone 7.5 mg /ibuprofen 200 mg ) , promethazine 12.5 mg , acetaminophen Ultracet ( tramadol HCl 37.5 mg/acetaminophen 325 mg ) fast fed condition .</brief_summary>
	<brief_title>A Four-Period , Four-Treatment , Four-Way Relative Bioavailability Study CL-108 Under Fed Fasted Conditions</brief_title>
	<detailed_description />
	<mesh_term>Hydrocodone</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<criteria>Written inform consent Subject 's body mass index ( BMI ) must 18 30kg/m2 ( inclusive ) , subject must weigh minimum 50 kg ( 110lb ) Abide study restriction Acceptable birth control measure Ability attend study visit Vital sign per protocol Willing consume high calorie meal within designated time frame Clinically significant medical history Clinically significant abnormal finding History presence allergic adverse response hydrocodone , ibuprofen , acetaminophen , nonsteroidal antiinflammatory drug ( NSAIDs ) , promethazine , relate drug . Has smoke use tobacco product within 60 day prior first dose study medication Has donate blood plasma within 30 day prior first dose study medication Has participate another clinical trial ( randomized subject ) within 30 day prior first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Plasma concentration</keyword>
	<keyword>Time plasma concentration</keyword>
	<keyword>Elimination rate constant</keyword>
	<keyword>Elimination half life</keyword>
	<keyword>Area curve</keyword>
</DOC>